Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention | NEJM

Vaccine made of live malaria parasites shows early success

A new antimalarial compound can rapidly clear out malaria parasites in infected mice with a single dose while largely avoiding the development of treatment resistance.

Malaria vaccine becomes first to achieve WHO-specified 75% efficacy goal

Researchers have shown ‘gene drive’ technology that suppressed populations of a malaria-carrying mosquito in a year-long experiment mimicking natural environments.

Drug researchers discover potent class of molecules that kills malaria parasite

Trial (n=56 people) of a malaria vaccine candidate (PfSPZ-CVac) found the highest doses resulted in a vaccine efficacy of up to 87.5%

mRNA vaccine yields full protection against malaria in mice

mRNA vaccine yields full protection against malaria in mice

First vaccinations have now begun in Mali in a phase III trial of a malaria vaccine developed at the University of Oxford